WAPO gift link.
1 Like
Interesting article- would worry about lowering immune response.
3 Likes
Rapamycin’s growing popularity mirrors the rise of longevity medicine. Altos Labs, which raised $3 billion,
Just follow the money. And lack of research.
Now apply the law of unintended consequences.
4 Likes
Interesting that the FDA does not consider aging a disease that needs to be treated, so to be able to market their aging cures these companies will have to come up with a legitimate label first.
2 Likes
America suffers from diseases of excess, not insufficiency. Yet, we’re always looking for a magic cure.
I don’t pay much attention to people like Attia and others who use intuition to make medical conclusions. His intuition used to tell him that statins were bad. That cost me a significant amount of atherosclerosis following that advice.
I prefer to actually know how things behave in large randomized trials rather than ingesting stuff willie nillie. If Matt Kaberlein and Eric Topol don’t routinely take Rapamycin, that should tell you something.
2 Likes
Statins work well for many people.
But some people have trouble with unwanted effects, like increased blood sugar / HbA1c / T2 diabetes, or muscle pain.
Every drug has unwanted side effects for some. He was against anyone using them.
When? Seems like he favors their use generally now.
During the era of his Eating Academy blog, when he was a ketosis zealot. He didn’t say everyone should avoid them, but preached the negatives of statins heavily.
This topic was automatically closed 180 days after the last reply. If you’d like to reply, please flag the thread for moderator attention.